Sixth Annual Health Law Year in P/Review image

December 12, 2017 8:00 AM - 5:00 PM
Conferences
2017-2018
Wasserstein Hall, Milstein East AB
Harvard Law School, 1585 Massachusetts Ave., Cambridge, MA

Description

The Sixth Annual Health Law Year in P/Review symposium will feature leading experts discussing major developments during 2017 and what to watch out for in 2018. The discussion at this day-long event will cover hot topics in such areas as health policy under the new administration, regulatory issues in clinical research, law at the end-of-life, patient rights and advocacy, pharmaceutical policy, reproductive health, and public health law. 

The Sixth Annual Health Law Year in P/Review is sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Harvard Health Publications at Harvard Medical School, the Program On Regulation, Therapeutics, And Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital, and the Center for Bioethics at Harvard Medical School. 

The full agenda will be posted here in fall 2018!

Register

This event is free and open to the public. Check back here in the fall for registration information.

Learn More 

How were our health law and policy predictions for 2016? Check out videos of all of the presentations at the 5th Annual Health Law Year in P/Review to find out! 

Want updates to come straight to your inbox? Sign up for our newsletter!

The Sixth Annual Health Law Year in P/Review is sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Program On Regulation, Therapeutics, And Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. 

Tags

aging   bioethics   biotechnology   clinical research   end-of-life   health care finance   health care reform   health law policy   human subjects research   human tissue   pharmaceuticals   public health   regulation   reproductive rights   reproductive technologies